Psoriasis, the success of the treatment is based on trust and the relationship continued over time between doctor and patient –

by time news

Psoriasis is a chronic disease, from which it is not cured, but which is now increasingly controlled thanks to the arrival of new drugs that today allow you to have clean skin, free from the itchy areas typical of the disease. It would be a mistake to consider it only a dermatological problem: it is now certain, in fact, a link with different types of joint, metabolic, cardiovascular and intestinal disorders. In order to guarantee a good quality of life to the nearly two million Italians living with psoriasis, a constant and trusting relationship between the patient and his dermatologist is therefore essential, in order to better calibrate the numerous therapeutic opportunities available and to better monitor the psycho-physical health of patients.

Talk to your doctor

Coming out into the open and being examined by a specialist allows the psoriatic patient to have his skin disease treated in the best possible way and to prescribe a personalized treatment. The choice of therapy, in fact, depends on the extent of the disease, the impact of the disease on the patient’s quality of life and the simultaneous presence of other pathologies (such as arthritis, hypertension, diabetes). The Dimension T awareness campaign based on three T’s for a new approach to psoriasis was born from these assumptions: T as Trust, which in English means trust, to be exercised in the relationship with the dermatologist and towards the prescribed treatments; T as the most suitable therapy for each patient; T for Time, or the time to find for oneself. The initiative, promoted by Janssen Italia, born in 2019 from the collaboration between doctors and patient associations and invites you to trust the dermatologist of specialized treatment centers to receive a precise diagnosis and evaluate the therapy. skin means offering a better quality of life to the patient, which is a fundamental aspect to be taken into consideration – says Giovanna Malara, chief of dermatology at the Reggio Calabria Hospitals -. The quality of life of the psoriatic patient, in fact, is strongly compromised considering that it is an inflammatory, systemic disease characterized by lesions often in visible areas that inevitably affect the psychological aspect, relationships and work activity. Especially when you suffer from it in a severe form, in fact, embarrassment and malaise can turn patients into anxiety, depression, isolation. Thanks to the wide availability of specific drugs, the dermatologist can decide which inflammatory mechanism to block, thus controlling the disease effectively and over the long term – explains Antonio Costanzo, director of Dermatology at the Humanitas Clinical Institute in Milan -. The effectiveness of a treatment today is measured in the reduction of the number of lesions, which must be at least 90%, and in the significant improvement in the quality of life. Also taking into account that current treatments have a very high safety profile and can also be taken for long periods.


Understanding what the patient’s needs are and establishing a relationship of trust allows the specialist to choose the most suitable treatment for each individual case. The therapies include “local” products, such as creams, gels and ointments, and phototherapy that are used for mild forms – explains Piergiorgio Malagoli, Head of Dermatology and PSOCARE Center at the IRCCS Policlinico San Donato in Milan -. In severe forms, instead, systemic drugs (tablets or subcutaneous injections) of the traditional type such as methotrexate, cyclosporine and retinoids, or new biological drugs can be used. Still too many patients are not adequately informed about the various therapeutic opportunities and their efficacy, and are often discouraged and disillusioned with any treatment. To complicate matters there is the fact that psoriasis has a course characterized by phases of remission alternating with phases of worsening. a disease with a complex nature, of a multifactorial type, ie genetic, immunological and environmental factors contribute to its development – concludes Stefano Piaserico, head of the Veneto Regional Center for Psoriasis and Associate Professor at the University of Padua -. It is important that patients are followed by all the necessary specialists, in addition to the dermatologist: collaboration is essential for a multidisciplinary approach because psoriasis, like other chronic systemic inflammatory diseases, is associated with and determines the increased risk of other diseases, such as cardiological, metabolic and hepatic.

November 29, 2021 (change November 29, 2021 | 20:01)

© Time.News

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.